Fig. 8From: Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancerExploring the expression of core DEGs in vitro and their prognostic roles in CRC. a SATB-2, ORP-1, MYB, and CDX-2 were downregulated after cetuximab treatment. b Patients with high expression levels of core DEGs in primary tumors exhibited a tendency to experience a longer progression-free survival time. **, pā<ā0.01, ***, pā<ā0.001, ns, pā>ā0.05. DEGs: Differentially expressed genes. CRC: Colorectal cancerBack to article page